Real Alpha
Try Pro free

Moonshots · 3 min · Oct 28, 2026

Warhound plans a repeatable supply of engineered working dogs

Peter Diamandis describes Warhound’s plan to edit and clone high-performing working dogs, and shares its $200M raise at a $1.2B valuation. The service-dog supply gap makes this a concrete bioengineering bet.

Peter Diamandis, Host

Founder, XPRIZE

Co-founded Singularity University and founded Zero-G; co-wrote the books Abundance and Bold.

  • Salim Ismail, Host · Founder, Open ExO

    Co-wrote Exponential Organizations; was Singularity University's founding executive director; sold Ångströ to Google.

  • Dave Blundin, Host · Founder & GP, Link Ventures

    Has co-founded 23 companies; founding CEO of Vestmark and chairman of insurance marketplace EverQuote.

  • Alexander Wissner-Gross, Host · Founder, Reified

    Has backed and advised 40+ tech companies, directly and through 021T Capital and Reified; writes The Innermost Loop.

About this segment

Peter Diamandis describes Warhound’s plan to edit and clone high-performing working dogs, and shares its $200M raise at a $1.2B valuation. The service-dog supply gap makes this a concrete bioengineering bet.

From “Anthropic’s $2T IPO, Elon Predicts Neocloud Death, and China’s Kimi Catches Up | #306”, Oct 28, 2026. Watch the full episode

“today more than 80 percent of working dogs come from Europe and fewer than half of them are fit for service.”
Peter Diamandisat 1:33:47 · Moonshots1:33:47

Takeaways

  1. More than 80% of working dogs come from Europe.
  2. Warhound plans to edit traits and clone high-performing dogs.
  3. It raised $200M at a $1.2B post-money valuation.

In this episode

Full episode
  1. 36:41Anthropic’s safety trust may weaken shareholder control6:22
  2. 54:32Kimi’s open weights are closing the frontier gapPro pick 8:27
  3. 31:35Anthropic now earns $2.08 per compute dollar5:12
  4. 1:04:11AI models are becoming capable enough to use existing software5:30

  5. 1:33:18Warhound plans a repeatable supply of engineered working dogs2:36

Up next · MTSBenchmarks can punish capable models for unfair reasonsPro pick 5:35

Transcript

Transcribed by machine (Whisper) from the episode’s audio, so a word may be off here and there.

  1. 1:33:30

    uh i'm going to move us forward uh the next story is one that i'm personally invested in through neogenesis it's a company called warhound uh here's the backstory so ben lamb ceo of colossal and palmer lucky founder of andrel met at a conference about a year ago just after colossal had brought back the dire wolf from extinction uh creating a heavier more powerful designed wolf Palmer raised a specific problem that he was seeing in the supply chain for America's working dogs, typically used for search and rescue, police or military duty.

  2. 1:33:58

    The problem that Palmer noted is that today more than 80 percent of working dogs come from Europe and fewer than half of them are fit for service. Many wash out because of inherited problems like hip dysplasia, poor eyesight or cancer. Ben and Palmer answered that question by creating Warhound. It's a company that takes cell lines from the best Belgian Milanese or German Shepherds, edit out the bad genes, enhance things like endurance, scent detection, intelligence, size, hearing, strength, and then clone the resulting dogs that were engineered so you get the same performing dog every time.

  3. 1:34:36

    Now, you can think of the cloned dog as becoming a catalog number, cloned and raised on demand. And here's an image from the recent release of Warhound. Actually, it was leaked. It was not supposed to go public for another six months. Andrel adds the tech on top of the dog, so armored vests and sensors and feed. data to the handlers. As Ben Lamb put it, Colossal is building Captain America. Andrel is building the Iron Man suit. Warhound came out of stealth with $200 million of investments from In-Q-Tel, Sequoia, 8VC, and my own fund, Neogenesis, at a $1.2 billion post-money valuation.

  4. 1:35:14

    For background, I think I haven't mentioned this on the pod, Neogenesis is a $200 million fund that I started with Dr. Yanni Psaltis. It's investing in Colossal and all the spin-outs, including Warhound. So the first clone dogs are due early next year, and they can be in service by two years from now. It's worth noting that Warhound is working with the American Humane Society to certify the process and the training. So Salim, let's go to you first. What are your